Removing the most dire warning from hormonal therapies to treat menopause is likely the right call, women’s health experts say, but exuberance for the treatments could be getting ahead of the evidence.

Since 2003, the U.S. Food and Drug Administration required a “black box” warning — reserved for the most serious side effects — on products that use estrogen, progesterone or both to treat symptoms such as hot flashes and vaginal dryness. The black box warned of an increased risk of blood clots and certain heart problems.

On Monday, U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. announced that providers would no longer see the black box, describing the decision to place the warning as a betrayal of women that denied them “strength, peace and dignity” and may h

See Full Page